Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
Crossref DOI link: https://doi.org/10.1007/s40618-017-0779-7
Published Online: 2017-11-07
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kotańska, Magdalena
Kulig, Katarzyna
Marcinkowska, Monika
Bednarski, Marek
Malawska, Katarzyna
Zaręba, Paula
Funding for this research was provided by:
National Science Center in Poland (DEC-2011/03/B/NZ7/00635)
License valid from 2017-11-07